P392: PHARMACOLOGICAL INHIBITION OF SYK CONFERS ANTI-PROLIFERATIVE AND NOVEL ANTI-TUMOR IMMUNE RESPONSES IN AML. (23rd June 2022) - Carvajal, L. A.; Robinson, B.; Kosaka, Y.; Jacob, T.; Lee, J.; Hood, T.; Baker, K.; Kaempf, A.; Amara, S. N.-A.; Pucilowska, J.; Lind, E.; Tognon, C.; et al.